001), Triglycerides (P = 0.002), total cholesterol (P = 0.001) level; and significantly lower high density lipoprotein (P = 0.013) values. Mean survival (patient-months) of patients with MS (30.7 (95%CI 27.1–34.3)) was significantly inferior to that of patients without MS (55.6 (95% CI 50.8–60.4), P = 0.001). Mean technique survival of patients with MS was also significantly lower (38.9 (95% CI 35.9–41.9)) compared to that of patients without MS (61.5 (95% CI 58.3–64.7),

P = 0.039). On univariate Cox regression analysis diastolic BP (P = 0.003), Systolic BP (P = 0.026), hypertension (HTN) (P = 0.001) and MS (P = 0.001) were found to be independent predictors of mortality. However on multivariate Cox hazard regression analysis, only MS (HR 5.39 (95% CI 2.06–14.14), P = 0.001) was found to be the significant predictors of mortality in these patients. Among the factors other than components of MS, the presence of comorbidities (P = 0.029), Inhibitor Library clinical trial serum albumin (P = 0.042), non-HDL cholesterol (P = 0.003), total cholesterol/HDL (P = 0.001) and MS (P = 0.001) were important factors predicting mortality on univariate Cox regression, while only MS (P = 0.001) and serum albumin (P = 0.013) were the independent factors predicting mortality on multivariate analysis.

Prevalence of MS in non-diabetic PD patient is high and predicts long term patient and technique survival. “
“Myocardial perfusion imaging (MPI) with SPECT (single photon emission computerized tomography) is commonly used for selleck compound preoperative renal transplant assessment. We performed an audit to evaluate the prognostic value of MPI in this cohort. Between 1999 and 2009, 838 transplants were performed in South Australia. A total of 387 patients had

393 preoperative MPI in three hospitals. Using a statewide electronic clinical information system (OACIS) cardiac events, MPI results (positive: any reversible defect; negative: fixed defects and normal), clinical follow up and comorbidities (diabetes and hypertension) were determined. End-point events were ‘soft’: admission with angina, percutaneous intervention or bypass; or ‘hard’: myocardial infarction or cardiac death. The end-point event rates were determined using Kaplan–Meier curves. Multivariate analyses were Exoribonuclease performed for age (60 years), gender, diabetes and hypertension. For negative MPI the event rates in dipyridamole stress were compared with tachycardic stress. Soft events: There was a statistically significant lower event rate for MPI negative versus positive, 3.9% versus 20.8% (hazard ratio 4.4 confidence interval: 2.1–9.6, P < 0.001) at 5 years of follow up – no effect from age, gender, diabetes and hypertension. Hard events: There was a lower event rate for MPI negative versus positive (also unaffected by age, gender, hypertension and diabetes) but the result was not statistically significant, P = 0.153. For negative MPI the soft and hard event rates were similar for dipyridamole and tachycardic stress.